Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Samuel A Gold

Showing results (21-30 of 26) with videos related to

Pageof 3
Sort By:
You have reached the last page of results.This site can display upto 26 results.
Urologic Oncology|March 19, 2021
Risk of adverse pathology at prostatectomy in the era of MRI and targeted biopsies; rethinking active surveillance for intermediate risk prostate cancer patientsJonathan B Bloom, Michael A Daneshvar, Amir H Lebastchi, et al.
Urology|July 16, 2025
Patterns of Outpatient Urinalysis Testing and the Detection of Microscopic HematuriaRichard S Matulewicz, Samuel A Gold, Fady Baky, et al.
Urologic Oncology|April 20, 2019
mpMRI preoperative staging in men treated with antiandrogen and androgen deprivation therapy before robotic prostatectomySamuel A Gold, David J VanderWeele, Stephanie Harmon, et al.
BJU International|May 30, 2019
Use of multiparametric magnetic resonance imaging and fusion-guided biopsies to properly select and follow African-American men on active surveillanceJonathan B Bloom, Amir H Lebastchi, Samuel A Gold, et al.
Urologic Oncology|August 7, 2022
Practice trends for perioperative intravesical chemotherapy in upper tract urothelial carcinoma: Low but increasing utilization during minimally invasive nephroureterectomyAlexander P Kenigsberg, Gianpaolo Carpinito, Samuel A Gold, et al.
JAMA Surgery|July 2, 2025
Rizedisben in Minimally Invasive Surgery: A Nonrandomized Clinical TrialSamuel A Gold, Maria M Pere, Melissa Assel, et al.
Pageof 3

Showing results (21-30 of 26) with videos related to

Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 26 results.
Urologic Oncology|March 19, 2021
Risk of adverse pathology at prostatectomy in the era of MRI and targeted biopsies; rethinking active surveillance for intermediate risk prostate cancer patientsJonathan B Bloom, Michael A Daneshvar, Amir H Lebastchi, et al.
Urology|July 16, 2025
Patterns of Outpatient Urinalysis Testing and the Detection of Microscopic HematuriaRichard S Matulewicz, Samuel A Gold, Fady Baky, et al.
Urologic Oncology|April 20, 2019
mpMRI preoperative staging in men treated with antiandrogen and androgen deprivation therapy before robotic prostatectomySamuel A Gold, David J VanderWeele, Stephanie Harmon, et al.
BJU International|May 30, 2019
Use of multiparametric magnetic resonance imaging and fusion-guided biopsies to properly select and follow African-American men on active surveillanceJonathan B Bloom, Amir H Lebastchi, Samuel A Gold, et al.
Urologic Oncology|August 7, 2022
Practice trends for perioperative intravesical chemotherapy in upper tract urothelial carcinoma: Low but increasing utilization during minimally invasive nephroureterectomyAlexander P Kenigsberg, Gianpaolo Carpinito, Samuel A Gold, et al.
JAMA Surgery|July 2, 2025
Rizedisben in Minimally Invasive Surgery: A Nonrandomized Clinical TrialSamuel A Gold, Maria M Pere, Melissa Assel, et al.
Pageof 3